Difference between revisions of "Oxazepam"
From Psychiatrienet
(Created page with '{{Drug | name = oxazepam | type = benzodiazepine | group = benzodiazepine | CAS = 604-75-1 | ChemSpiderID = 4455 | ATC = N05BA04 | pubchem = 4616 | drugbank = APRD01152 | medscap...') |
|||
(4 intermediate revisions by the same user not shown) | |||
Line 19: | Line 19: | ||
| halflife_ref = <ref name="informatorium" /> | | halflife_ref = <ref name="informatorium" /> | ||
| ct = 3.5 | | ct = 3.5 | ||
− | | ct_ref = <ref>{{pts}}</ref> | + | | ct_ref = <ref>{{pts|1414|1|11}}</ref> |
| metabolites = 1 | | metabolites = 1 | ||
| metabolites_ref = <ref name="drugs">{{DRUGSCOM|oxazepam}}</ref> | | metabolites_ref = <ref name="drugs">{{DRUGSCOM|oxazepam}}</ref> | ||
| administration = O | | administration = O | ||
− | |||
− | |||
| DDD = 50 | | DDD = 50 | ||
+ | | DDD_ref = <ref>{{WHOCC|N05BA04}}</ref> | ||
+ | | dmax = 200 | ||
+ | | dmax_ref = | ||
| ctox = 3000-5000 | | ctox = 3000-5000 | ||
| ctox_ref = <ref>{{Toxicology|29}}</ref> | | ctox_ref = <ref>{{Toxicology|29}}</ref> | ||
| <includeonly> isswitch = 1</includeonly> | | <includeonly> isswitch = 1</includeonly> | ||
}} | }} |
Latest revision as of 12:39, 18 June 2010
oxazepam | |||||||||||||||||||
Type | benzodiazepine | ||||||||||||||||||
Group | benzodiazepine | ||||||||||||||||||
links | |||||||||||||||||||
ATC-code | N05BA04 | ||||||||||||||||||
PubChem | 4616 | ||||||||||||||||||
PubMed | oxazepam | ||||||||||||||||||
Drugs.com | oxazepam | ||||||||||||||||||
Kompas (Dutch) | oxazepam | ||||||||||||||||||
Wikipedia | oxazepam | ||||||||||||||||||
|
"-5000" can not be assigned to a declared number type with value 3000.
oxazepam is a benzodiazepine in the group benzodiazepine.
- ↑ WHO Collaborating Centre for Drug Statistics Methodology ATC=N05BA04
- ↑ NVZA; Toxicology.org; Monografie 29 (dutch)
- ↑ KNMP; Informatorium Medicamentorum 2009; Inleidende tekst "Benzodiazepineagonisten" (dutch)
- ↑ 4.0 4.1 KNMP; Informatorium Medicamentorum 2023; Monografie "oxazepam" (Dutch)
- ↑ The Lundbeck Institute; Psychotropics; Terminal Plasma Half-lives